Mirae Asset Global Investments Co., Ltd. Pmv Pharmaceuticals, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$1.51 - $3.12 $23,392 - $48,335	15,492 New	15,492 $26,000
Q3 2023 Oct 26, 2023	BUY	$6.01 - $8.93 $619 - $919	103 Added 0.62%	16,630 $102,000
Q2 2023 Aug 10, 2023	SELL	$3.94 - $6.27 $358 - $570	-91 Reduced 0.55%	16,527 $103,000
Q1 2023 May 04, 2023	SELL	$4.77 - $9.16 $143 - $274	-30 Reduced 0.18%	16,618 $79,000
Q4 2022 Feb 09, 2023	BUY	$8.17 - $12.95 $138 - $220	17 Added 0.1%	16,648 $144,000
Q3 2022 Nov 10, 2022	BUY	$11.4 - $17.18 $189,593 - $285,720	16,631 New	16,631 $198,000

41.9M

3.1K

1.7K

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $72.5M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.